A comparison of the inflammatory control of asthma provided by one inhalation of Symbicort Turbuhaler 160/4.5 microg/inhalation b.i.d. plus as-needed versus one inhalation of Symbicort Turbuhaler 320/9 microg/inhalation b.i.d. + one inhalation of Pulmicort Turbuhaler 400 microg/dose b.i.d. plus terbutaline Turbuhaler 0.4 mg/inhalation as-needed. A 12-month, randomised, double-blind, parallel-group, active controlled, multinational, phase III B study in adult patients with asthma, EOS
Latest Information Update: 02 Sep 2021
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide; Terbutaline
- Indications Asthma
- Focus Pharmacodynamics
- Sponsors AstraZeneca
- 11 Jan 2008 Status changed from in progress to completed.
- 17 Nov 2006 Status change
- 22 Nov 2005 New trial record.